Molecules/UBLITUXIMAB

UBLITUXIMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: B-lymphocyte antigen CD20 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

BriumviBRIUMVIEMAB-6EMAB6LFB-R 603LFBR-603LFBR603R-603R603TG-1101TG1101TGT-1101TGT1101TGTX-1101TGTX1101

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to UBLITUXIMAB

Loading drug network...